NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards

  • Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New funding provides for necessary resources to regain compliance with reporting obligations and listing standards.